Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer

Summary

This clinical trial refines and tests the effect of a decision aid in improving decision-making in patients with non-small cell lung cancer. Patients with cancer want to be informed about their diagnoses, treatment procedures and goals of treatment. They also seek active roles in decision-making. Shared decision-making (SDM) is the process of clinician and patient jointly participating in a health decision after discussing the options, benefits and harms, and considering the patient's values, preferences, and circumstances. SDM can improve patient involvement in decision making, satisfaction, health care quality, and quality of life. Decision aids can improve patient knowledge, create more realistic outcome expectations; reduce decisional conflict, distress, depression and uncertainty; and improve physician-patient communication and quality of life, compared with no decision aid. This trial's main aim is to evaluate the feasibility and efficacy of a decision aid in patients with non-small cell lung cancer.

Conditions

• Lung Non-Small Cell Carcinoma
• Stage I Lung Cancer AJCC v8
• Stage II Lung Cancer AJCC v8
• Stage III Lung Cancer AJCC v8
• Stage IV Lung Cancer AJCC v8

Interventions

OTHER

Best Practice

Receive usual/standard of care

OTHER

Informational Intervention

Receive conversation tool

OTHER

Questionnaire Administration

Ancillary studies - Baseline and follow-up questionnaires

Sponsors & Collaborators

• Oregon Health and Science University

  collaborator OTHER

• ATS Foundation

  collaborator UNKNOWN

• Hildegard Lamfrom Endowment

  collaborator UNKNOWN

• Medical Research Foundation, Oregon

  collaborator OTHER

• OHSU Knight Cancer Institute

  lead OTHER

Principal Investigators

• Donald Sullivan · OHSU Knight Cancer Institute

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

PARALLEL

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-08-07

Primary Completion

2026-12-31

Completion

2026-12-31

Countries

• United States

Study Locations